Roivant Sciences (ROIV) News Today

Exchange Traded Concepts LLC purchased a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 196,480 shares of the company's stock, valued at approximatel

Dimensional Fund Advisors LP acquired a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 252,721 shares of the com

Handelsbanken Fonder AB boosted its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 67.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 191,409 shares of the company's stock a

The Manufacturers Life Insurance Company cut its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 19.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 321,959 shares of the company's

Algert Global LLC cut its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 68.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 46,331 shares of the company's stock after sell

Clearbridge Investments LLC boosted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 51.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,860,536 shares of the company's stock after p

Point72 Asset Management L.P. grew its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 40.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 647,126 shares of the company's stock after purchasin

Marshall Wace LLP lifted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1,221.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 714,760 shares of the company's stock after purchasing an a

Pacer Advisors Inc. raised its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1,287.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,500 shares of the company's stock after acquiring an additional 51,5

DME Capital Management LP grew its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 14.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,810,960 shares of the company's stock afte

Affinity Asset Advisors LLC cut its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 29.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 351,587 shares of the company's st

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) have received an average rating of "Moderate Buy" from the ten brokerages that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recom

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders bought 5,202 call options on the company. This is an increase of approximately 128% compared to the typical volume of 2,278 call options.

Farallon Capital Management LLC lessened its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 25.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 673,000 shares of the company's stock after selling 225,6

Integral Health Asset Management LLC trimmed its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 33.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 400,000 shares o

Rubric Capital Management LP boosted its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 15.0% in the second quarter, according to its most recent filing with the SEC. The firm owned 23,000,000 shares of the company's stock after acquiring an additional 3,000,000 shares d

Cantor Fitzgerald restated an "overweight" rating on shares of Roivant Sciences in a report on Thursday.

Roivant Sciences (NASDAQ:ROIV) Shares Gap Up to $12.05

Pekin Hardy Strauss Inc. acquired a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 54,050 shares of the company's stock, valued at approximately $571,000. Several other hedge f

Sofinnova Investments Inc. grew its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 86.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,868,412 shares of the company's stock after purchasing an additional 866,708 shares du

Rhumbline Advisers decreased its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 7.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 886,493 shares of the company's stock after selling 70,856 shares d

Bank of America raised their price target on shares of Roivant Sciences from $12.00 to $12.50 and gave the stock a "neutral" rating in a research note on Wednesday.

HC Wainwright reissued a "buy" rating and issued a $18.00 price objective on shares of Roivant Sciences in a research note on Wednesday.

Pier Capital LLC increased its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 29.5% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 425,087 shares of the company's stock after acquiring an addit

Monaco Asset Management SAM purchased a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 40,000 shares of the company's stock, valued at approximately $423,000. Several other